We are live on
!
Find out more
CMMB
Chemomab Therapeutics
CMMB
CMMB
15 hedge funds and large institutions have $552K invested in Chemomab Therapeutics in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7% more funds holding
Funds holding: 14 → 15 (+1)
1.08% less ownership
Funds ownership: 5.97% → 4.89% (-1.1%)
9% less capital invested
Capital invested by funds: $606K → $552K (-$54.2K)
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$67.7K |
| 2 |
Jane Street
New York
|
-$25.7K |
| 3 |
VF
Virtu Financial
New York
|
-$18K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.84K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$656 |